By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BrainStorm Cell Therapeutics Inc. 



Tel Aviv      Israel
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
BrainStorm Cell Therapeutics Inc. Says Stem Cell Drug Benefits ALS Patients in Mid-Stage Trial 4/21/2015 5:57:53 AM
BrainStorm Cell Therapeutics Inc. To Present Positive Nurown Phase 2a Clinical Data At American Academy of Neurology Annual Meeting 4/14/2015 9:40:22 AM
BrainStorm Cell Therapeutics Inc. Announces Financial Results For 2014 And Provides Business Update 3/26/2015 11:31:09 AM
BrainStorm Cell Therapeutics Inc. To Report Fourth Quarter And Full Year 2014 Financial Results On Thursday, March 26 3/20/2015 7:51:04 AM
BrainStorm Cell Therapeutics Inc. To Present At 3rd Annual Regen Med Investor Day On March 25 In New York 3/18/2015 9:41:52 AM
BrainStorm Cell Therapeutics Inc. Receives Notice Of Allowance For Its Nurown Technology Platform From Israel's Patent Office 2/9/2015 8:54:14 AM
BrainStorm Cell Therapeutics Inc. CEO To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/4/2015 11:14:18 AM
BrainStorm Cell Therapeutics Inc. Announces Positive DSMB Recommendation In Ongoing Phase 2 Trial With NurOwn™ In ALS 2/3/2015 7:22:40 AM
BrainStorm Cell Therapeutics Inc. Announces Exceptional Preclinical Results Of Nurown™ In Mouse Autism Model 1/26/2015 10:04:50 AM
BrainStorm Cell Therapeutics Inc. Enters Into Warrant Exercise Agreement For Approximately $13 Million In Proceeds 1/8/2015 8:34:38 AM
12345678910...
//-->